Keyphrases
Adjusted Odds Ratio
17%
Adult Recipients
13%
Apologizing
13%
Arteriolar Hyalinosis
13%
Author Names
13%
Cell Therapy
26%
Center Volume
13%
Chronic Kidney Disease
20%
COVID-19
13%
Death-censored Graft Survival
22%
Deceased Donor
13%
GLP-1 Receptor Agonist
13%
Graft Failure
44%
Graft Function
26%
Graft Loss
26%
Hazard Ratio
16%
Hepatitis C
15%
High Risk
18%
High-risk Population
16%
Histologic Changes
15%
HLA-identical
13%
Hypertension
20%
Immunosuppression
30%
Kidney
84%
Kidney Allograft Failure
13%
Kidney Biopsy
20%
Kidney Transplant
53%
Kidney Transplant Outcomes
15%
Kidney Transplant Recipients
35%
Kidney Transplantation
48%
Living Kidney Donor
40%
Long-run Risk
17%
Mesangial Expansion
20%
Microstructural Characteristics
14%
Nephrolithiasis
13%
Pancreas Allograft
26%
Patient Survival
16%
Renal Allograft Survival
15%
Renal Transplantation
26%
Retransplantation
13%
Risk Factors
22%
Simultaneous Pancreas-kidney Transplantation
26%
Stone Formers
13%
Survival Time
13%
Transplant Outcomes
26%
Transplant Recipients
14%
Transplantation
47%
Type 1 Diabetes Mellitus (T1DM)
30%
Type 2 Diabetes Mellitus (T2DM)
18%
Type I Diabetes
26%
Medicine and Dentistry
Allograft
36%
Ambulatory Blood Pressure
13%
Biopsy Technique
43%
Body Mass Index
11%
Cancer
14%
Cell Therapy
26%
Chronic Kidney Disease
20%
Comorbidity
8%
Computer Assisted Tomography
10%
COVID-19
13%
Echography
13%
End Stage Renal Disease
17%
Fine Particulate Matter
13%
Glomerular Filtration Rate
13%
Glomerulus
17%
Glucagon-Like Peptide-1 Agonist
13%
Graft Failure
65%
Graft Survival
24%
Hazard Ratio
20%
Hepatitis C
13%
Hepatitis C Virus
13%
High Risk Population
15%
Hyaline Degeneration
26%
Immunosuppressive Treatment
33%
Immunotherapy
13%
Insulin Dependent Diabetes Mellitus
26%
Kidney Allograft
34%
Kidney Function
31%
Kidney Graft
100%
Kidney Hypertrophy
22%
Kidney Pancreas Transplantation
23%
Kidney Stone
13%
Kidney Transplantation
76%
Left Ventricular Assist Device
13%
Living Donors
40%
Lung
13%
Maturity Onset Diabetes of the Young
15%
Nephrectomy
13%
Nephron
21%
Odds Ratio
22%
Percutaneous Aortic Valve Replacement
13%
Proteinuria
18%
Recurrent Disease
13%
Regulatory T Cell
13%
Renal Biopsy
29%
Retransplantation
13%
Survival Time
10%
Thrombotic Thrombocytopenic Purpura
13%
Type 2 Diabetes
13%
Virus
13%